The GF CSI Brand Name Drug Industry ETF seeks to replicate as closely as possible the price and yield performance of the CSI Innovative Drug Industry Index by investing in a portfolio comprised primarily of Chinese companies
The GF CSI Brand Name Drug Industry ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in China. The GF Fund Management fund’s base currency is CNY and the share class was registered 03.12.2020 with unique ISIN - CNE100004DF0. Main exchange is Shanghai SE and ticker symbol is 515120. The total expense ratio is 0.6%. The GF CSI Brand Name Drug Industry ETF (CNY) pays dividends 1 time(s) per year.